By Ionis Pharmaceuticals | December 20, 2017

Biogen, Ionis Enter New Collaboration to Identify Novel Therapies for the Treatment of SMA

By Ionis Pharmaceuticals | November 15, 2017

Ionis Licenses Novel Antisense Drug to Treat CNM to Dynacure

By Ionis Pharmaceuticals | August 15, 2017

Ionis to Independently Advance Inotersen and IONIS-FB-L Rx

By Ionis Pharmaceuticals | May 15, 2017

Ionis Pharmaceuticals Announces Phase 3 Results for Inotersen